Back

From Light Chain Cardiotoxicity to Arrhythmogenic Risk in AL Amyloidosis: Insights from hiPSC-derived cardiomyocytes

8 July 2026 (10:30 - 12:30)
Organised by: Logo
Seminar Presentation Part of: POSTER SESSION 2 Basic Science Delegate Premium access 50th EWGCCE Meeting 2026 WG on Cardiac Cellular Electrophysiology

42 More presentations in this session

Presentation thumbnail
A ZFPM2 regulatory region associated to Brugada syndrome plays an essential role in cardiac electrical activity and development
Abstract
Presentation thumbnail
Mechanobiological distinction of focal and conductive arrhythmias by AFM
Abstract
Presentation thumbnail
Promising QT-shortening effect of the endocannabinoid N-arachidonoyl-L-Serine (ARA-S) in a transgenic rabbit model of long QT syndrome type 1
Abstract
Presentation thumbnail
Human living cardiac slices as a platform for antiarrhythmic drug testing
Abstract
Presentation thumbnail
Electrophysiological characterization of human cardioids at different maturation stages
Abstract

Access the full session

Session thumbnail
POSTER SESSION 2

The Event

Event poster

50th EWGCCE Meeting 2026

8 July 2026 10:30 CET
You may be interested in
thumbnail
Congress Session
Cardiac amyloidosis and heart failure
20 May 2025
thumbnail
Congress Presentation
Cardiotoxicity in light chain amyloidosis: Insights from the first murine model with intramyocardial injection of patient-derived amyloidogenic light chains
26 August 2023
thumbnail
Congress Presentation
Differences between AL and transthyretin cardiac amyloidosis: a comparison of the echocardiographic morphological variables
22 May 2023
thumbnail
Congress Presentation
Exploring ATTR cardiomyopathy: the journey to improved outcomes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources